Abstract
Enabling the drug delivery systems with drug release monitoring function is of essential importance to enhance therapeutic effectiveness. Herein, we took a ship-in-a-bottle synthesis strategy to construct the upconversion nanocrystal and zeolite compounded drug delivery system with real-time monitoring function, by using desilicated ZSM-5 zeolite as drug carrier and NaYF4: Yb3+/Tm3+ nanocrystal as luminescent probe. Benefiting from the enlarged mesoporous in desilicated ZSM-5, the NaYF4: Yb3+/Tm3+ nanocrystals can be successfully loaded inside and the upconversion emission intensity of Tm3+ under 980 nm excitation was one order of magnitude enhanced after mild heat treatment. The drug release monitoring function were studied by using doxorubicin as model drug, the experimental results indicated that the upconversion emission intensity ratio of I802nm/I475nm can accurately evaluate drug release percentage. Further in vitro cytotoxicity evaluation suggested the doxorubicin-loaded UCNC@ZSM-5/DS/HT has excellent biocompatibility and is able to inhibit tumor cells effectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
